SlideShare a Scribd company logo
IMMUNODEFICIENCY DISEASES
GROUP 6A
GROUP MEMBERS
1. Alexandria Mungai
2. Keith Nyambeki
3. Lucy Muthoni
4. Elizabeth Makena Netia
5. Johnbosco Muema
6. Yvonne Mwita
7. Chris Karanja
DEFINITION
Immunodeficiency or immune
deficiency is the state in which
immune system’s ability to fight
infectious disease is compromised
or entirely absent.
TYPES
There are two types of immunodeficiency disorders:
1 Primary immunodeficiency PID: Inherited immune disorders resulting
from genetic mutations usually present at birth and diagnosed in
childhood.
2 Secondary immunodeficiency (SID): acquired immunodeficiency from a
disease or environmental factors such as HIV, malnutrition or medical
treatment e.g. chemotherapy.
CLASSIFICATION OF PRIMARY
IMMUNODEFICIENCY DISEASES
1. Humoral Immunodeficiencies
2. Cellular Immunodeficiencies
3. Combined immunodeficiencies
4. Disorders of complement
5. Disorders of phagocytosis
B CELL DEFICIENCY
• IgA deficiency
• IgG subclass deficiency
• Immunodeficiency with increased Igm
• Common variable immunodeficiency
• Transient hypogammaglobulinemia of infancy
• X linked agammaglobulinemia
X LINKED AGAMMAGLOBULINEMA
• In X-LA early maturation of B cells fails.
• Affect mails
• Few or no B cells in blood
• Very small lymph nodes and tonsils
• No Ig.
• Small amount of IgG in early age.
• Recurrent pyogenic infection.
IgA AND IgG SUBCLASS DEFICIENCY
• IgA deficiency is most common
• Patients tend to develop immune complex disease
• About 20% lack IgG2 and IgG4
• Susceptible to pyogenic infection
• Results from failure in terminal differentiation of B cells
IMMUNODEFICIENCY WITH INCREASED IgM
(HIgM)
• Results on patients with IgA and IgG deficiency
• Production of large amount of IgM >200 mg/dl of polyclonal IgM
• Susceptible to pyogenic infection.
• Formation of IgM to neutrophils, platelets and other blood components.
• Due to inability of B cells to isotype switching.
HYPOGLOBULINAEMIA OF INFANCY
Due to delay in IgG synthesis approximately up to 36 months.
In normal infants synthesis begins at 3 months.
Normal B lymphocytes
Probably lack help of T lymphocytes
DISORDERS OF T CELL
DiGeorge’s syndrome:
• Also known as Congenic thymic aplasia/hypoplasia.
• Associated with hypoparathythoidism, congenital heart disease, fish shaped mouth.
• Defects results from abnormal development of fetus during 6th-10th week of gestation when
parathyroid, thymus, lips, ears, and aortic arch are being formed.
T CELL DEFICIENCIES WITH VARIABLE DEGREES
OF B CELL DEFICIENCY
1.Ataxia-telangiectasia:
• Associated with a lack of coordination of movement (ataxia) and dilation of small blood vessels of
the facial area (telangiectasias).
• T-cells and their functions are reduced to various degrees.
• B cell numbers and IgM concentrations are normal to low.
• IgG is often reduced
• IgA is considerably reduced (in 70% of the cases).
• There is a high incidence of malignancy particularly leukemia in these patients.
• The defects arise from a breakage in chromosome 14 at the site of TCR and Ig heavy chain
genes.
WISKOTT-ALDRICH SYNDROME
• Associated with normal t cell numbers with reduced functions which get progressively worse.
• IgM concentrations are reduced but IgG level are normal
• Both IgA and IgE levels are elevated.
• Boys with this syndrome develop severe eczema.
• They respond poorly to polysaccharide antigens and are prone to pyogenic infection.
BARE LEUKOCYTE SYNDROME
• Due to defect in the MHC class II trans activator (CIITA) protein gene, which results in a lack of
class-II MHC molecule on APC.
• Patients have fewer CD4 cells and are infection prone.
• There are also individuals who have a defect in their transport associated protein (TAP) gene and
hence express the class-I MHC molecules and constantly are deficient in CD8+ T cells.
DEFECTS OF THE PHAGOCYTIC SYSTEM
• Defects of phagocytic cells ( numbers and/or functions) can lead to increased susceptibility
to a variety of infections.
Cyclic neutropenia:
• Its marked by low numbers of circulating neutrophil approximately every three weeks. The
neutropenia lasts about a week during which the patients are susceptible to infection. The
defect appears to be due to poor regulation of neutrophil production.
Chronic granulomatous disease (CGD):
CGD is characterized by marked lymphadenopathy, hepato-splenomegaly and chronic draining
lymph nodes.
In majority of patients with CGD, the deficiency is due to a defect in NADPH oxidase that
participate in phagocytic respiratory burst.
Leukocyte Adhesion Deficiency
• Leukocytes lack the complement receptor CR3 due to a defect in CD11 or CD18 peptides and consequently
they cannot respond to C3b opsonin.
• Alternatively there may be a defect in integrin molecules, LFA-1 or mac-1 arising from defective CD11a or
CD11b peptides, respectively.
• These molecules are involved in diapedesis and hence defective neutrophils cannot respond effectively to
chemotactic signals.
Chediak-Higashi syndrome
• This syndrome is marked by reduced (slower rate) intracellular killing and chemotactic movement
accompanied by inability of phagosome and lysosome fusion and proteinase deficiency.
• Respiratory burst is normal.
• Associated with NK cell defect, platelet and neurological disorders.
DISORDERS OF COMPLEMENT SYSTEM
• Complement abnormalities also lead to increased susceptibility to infections.
• There are genetic deficiencies of various components system, which lead to increased infections.
• The most serious among these is the C3 deficiency which may arise from low C3 synthesis or
deficiency in factor I or factor H.
SEVERE COMBINED IMMUNODEFICIENCY
• In about 50% of SCID patients the immunodeficiency is x-linked whereas in the other half the
deficiency is autosomal.
• They both characterized by an absence of T cell and B cell immunity and absence (or very low
numbers) of circulating T and B lymphocytes.
• Patients with SCID are susceptible to a variety of bacterial, viral, myotic and protozoan infections.
• The x-linked SCID is due to a defect in gamma-chain of IL-2 also shared by IL-4, -7, -11 and 15, all
involved in lymphocyte proliferation and/or differentiation.
• The autosomal SCIDs arise primarily from defects in adenosine deaminase (ADA) or purine
nucleoside phosphorylase (PNP) which results is accumulation of dATP or dGTP, respectively, and
cause toxicity to lymphoid stem cells.
SECONDARY IMMUNODEFICIENCY
Secondary immunodeficiency or acquired immunodeficiency, is the loss of immune function and
results from exposure to various agents (not a genetic or developmental problem).
The most common secondary immunodeficiency is Acquired Immunodeficiency Syndrome (AIDS),
which results from infection with the human immunodeficiency virus1 (HIV-1).
FOUR STAGES OF INFECTION
• Incubation period- the initial incubation period infection is asymptomatic and usually lasts between two and four
weeks.
• Acute infection- lasts an average of 28 days and can include symptoms such as:
1. Fever
2. Lymphadenopathy(swollen lymph nodes)
3. Pharyngitis(sore throat)
4. Rash
5. Myalgia(muscle pain)
6. Malaise
7. Mouth and esophageal sores
• Latency stage- shows few or no symptoms and last anywhere from two to twenty years and beyond.
• AIDS- shows as symptoms of various opportunistic infections
0.5% of HIV-1 infected individuals retain high levels of CD4 T-cells and a low or clinically undetectable viral load
without anti-retroviral treatment. These individuals are classified as HIV controllers or long-term non progressors
(LTNP).
The two main types of T-cells are the “helper ”T-cell and the cytotoxic T-cell. The T-helper population is further
divided into those which help B-cells (Th2) and those which help cytotoxic T-cells (Th1).
Therefore, in order for a B-cell to do its job requires the biochemical help of Th2 helper T-cells; and, for a cytotoxic T-
cell to be able to eliminate a damaged cell (say, a virally-infected cell), requires the biochemical help of a Th1 helper
T-cell.
The effect of HIV on the immune system is the result of a gradual (usually) elimination of the Th1 and Th2 helper T-
cell sub-populations.
IMMUNODEFICIENCY CAUSED BY DRUGS
Corticosteroids
• Cause changes in circulating
leukocytes.
• Depletion of CD4 cells.
• Monocytopenia.
• Decreased in circulating eosinophils
and basophils.
• Inhibition of T cell activation and B cell
maturation.
• Inhibit cytokine synthesis.
METHOTREXATE
• Structural analogue of folic acid.
• Blocks folic acid dependent synthetic pathways essential for DNA
synthesis.
• Prolonged use for treatment reduces immunoglobulin synthesis.
• CYCLOSPORIN
• Have severe effects on T cell signaling and functions.
• It binds to immunophilins which are believed to have a critical
role in signal transduction.
• Also inhibit IL2 dependent signal transduction.
OTHER CAUSES:
• Malnutrition
• Minerals
• Obesity
• Vitamins
NURSING MANAGEMENT FOR PATIENTS WITH
IMMUNODEFICIENCY DISEASES
• Nursing management includes assessment, patient teaching, and supportive care.
• Assessment of the patient for infection and for response to treatment is important if it is to be effective.
• Nursing care of patients with primary and secondary immunodeficiencies depends on the underlying cause of the immunodeficiency, the type of
immunodeficiency, and its severity.
• Because immuno-deficiencies result in a compromised immune system and high risk for infection, careful assessment of the patient’s immune status
is essential.
• The assessment focuses on history of past infec-tions, particularly the type and frequency of infection; signs and symptoms of any current skin,
respiratory, gastrointestinal, or genitourinary infection; and measures that prevent infection.
• The nurse monitors the patient for signs and symptoms of infection: fever; chills; cough with or without sputum; shortness of breath; difficulty
breathing; difficulty swallowing; white patches in the oral cavity; swollen lymph nodes; nausea; vomiting; persistent diarrhea; frequency, urgency, or
pain on urination; redness, swelling, or drainage from skin wounds; lesions on the face, lips, or perianal area; persistent vaginal discharge with or
without perianal itching; and persistent abdominal pain.
NURSING MANAGEMENT CONTINUED
• Because the inflammatory response may be blunted, the patient is monitored for subtle and unusual signs and changes in physical status.
• Vital signs and the development of pain, neurologic signs, cough, and skin lesions are monitored and reported.
• Pulse rate and respiratory rate should be counted for a full minute, as even subtle changes can signal deterioration in the patient’s clin-ical status
• Thorough auscultation and assessment of the breath sounds are also key in detecting changes in respiratory status.
• Any unusual response to treatment and any significant change in the patient’s clinical condition are promptly reported to the physician.
• The nurse also monitors laboratory values (ie, white blood cell count and differential cell count) for changes indicating infection.
• Culture and sensitivity reports from wound drainage, lesions, spu-tum, stool, urine, and blood are monitored to identify pathogenic organisms and
appropriate antimicrobial therapy.
• Changes in laboratory results and subtle changes in clinical status must be reported to the physician because the immunocompromised patient may
not develop typical signs and symptoms of infection.
NURSING MANAGEMENT CONTINUED
• Assessment also focuses on nutritional status; stress level and coping skills; use of alcohol, drugs, or tobacco; and general hy-giene, all of which may
affect immune function.
• Strategies the patient has used to reduce risk for infection are identified.
• Other aspects of nursing care are directed toward reducing the patient’s risk for infection, assisting with medical measures aimed at improving immune
status and treating infection, improving the nutritional status, and maintaining bowel and bladder function.
• These include careful hand hygiene, encouraging the patient to cough and perform deep-breathing exercises at regular inter-vals, and protecting the
integrity of the skin and mucous mem-branes.
• All health care personnel must use strict aseptic technique when performing invasive procedures, such as dressing changes, venipunctures, and bladder
catheterizations.
• Other aspects of nursing care include assisting the patient in managing stress and in adopting a lifestyle that enhances immune system function.
THANK YOU
THE END

More Related Content

Similar to IMMUNODEFICIENCY DISORDERS GROUP 6A.pptx

Congenital and Acquired Immunodeficiency
Congenital and Acquired ImmunodeficiencyCongenital and Acquired Immunodeficiency
Congenital and Acquired ImmunodeficiencyGifteeJRoumi
 
immunodef dis.pptx
immunodef dis.pptximmunodef dis.pptx
immunodef dis.pptxChinmoy Sahu
 
Vaccination in CKD patients
Vaccination in CKD patients Vaccination in CKD patients
Vaccination in CKD patients Chetan Somani
 
Pri & sec immuno deficiency
Pri & sec immuno deficiencyPri & sec immuno deficiency
Pri & sec immuno deficiencyPooja Sevak
 
Primary immunodeficiency disorders
Primary immunodeficiency disordersPrimary immunodeficiency disorders
Primary immunodeficiency disorderssaswati14
 
Systemic lupus erythematosis
Systemic lupus erythematosisSystemic lupus erythematosis
Systemic lupus erythematosisPurnima Kartha
 
Primary combined antibody and cellular immunodeficiencies
Primary combined antibody and cellular immunodeficienciesPrimary combined antibody and cellular immunodeficiencies
Primary combined antibody and cellular immunodeficienciesSai Hari
 
Combined T cells And Bcell Deficiency - SCID
Combined T cells And Bcell Deficiency - SCIDCombined T cells And Bcell Deficiency - SCID
Combined T cells And Bcell Deficiency - SCIDGirish Kumar K
 
Immunodeficiency Syndrome
Immunodeficiency SyndromeImmunodeficiency Syndrome
Immunodeficiency SyndromeHadi Munib
 
Common variable immunodeficiency
Common variable immunodeficiencyCommon variable immunodeficiency
Common variable immunodeficiencyFatima Awadh
 
Immunodeficiency disorders: inherited & acquired
Immunodeficiency disorders: inherited & acquiredImmunodeficiency disorders: inherited & acquired
Immunodeficiency disorders: inherited & acquiredOluwakemiTaiwo1
 
Immuno deficiency disorders
Immuno deficiency disordersImmuno deficiency disorders
Immuno deficiency disordersVamsi Chakradhar
 
Immunodeficiencies.pptx
Immunodeficiencies.pptxImmunodeficiencies.pptx
Immunodeficiencies.pptxOumaWinnie1
 
immunodeficeincy.pptx
immunodeficeincy.pptximmunodeficeincy.pptx
immunodeficeincy.pptxMohedLipan
 
COMMON VARIABLE IMMUNODEFICIENCY (CVID)
COMMON VARIABLE IMMUNODEFICIENCY (CVID)COMMON VARIABLE IMMUNODEFICIENCY (CVID)
COMMON VARIABLE IMMUNODEFICIENCY (CVID)Abdullatif Al-Rashed
 
SECONDARY IMMUNODEFICENCY...pptx
SECONDARY IMMUNODEFICENCY...pptxSECONDARY IMMUNODEFICENCY...pptx
SECONDARY IMMUNODEFICENCY...pptxAnaghaM35
 

Similar to IMMUNODEFICIENCY DISORDERS GROUP 6A.pptx (20)

Congenital and Acquired Immunodeficiency
Congenital and Acquired ImmunodeficiencyCongenital and Acquired Immunodeficiency
Congenital and Acquired Immunodeficiency
 
immunodef dis.pptx
immunodef dis.pptximmunodef dis.pptx
immunodef dis.pptx
 
Vaccination in CKD patients
Vaccination in CKD patients Vaccination in CKD patients
Vaccination in CKD patients
 
Pri & sec immuno deficiency
Pri & sec immuno deficiencyPri & sec immuno deficiency
Pri & sec immuno deficiency
 
Severe combined immunodeficiency - SCID
Severe combined immunodeficiency - SCIDSevere combined immunodeficiency - SCID
Severe combined immunodeficiency - SCID
 
Primary immunodeficiency disorders
Primary immunodeficiency disordersPrimary immunodeficiency disorders
Primary immunodeficiency disorders
 
immuno.pptx
immuno.pptximmuno.pptx
immuno.pptx
 
Systemic lupus erythematosis
Systemic lupus erythematosisSystemic lupus erythematosis
Systemic lupus erythematosis
 
Immunodeficiency Disorder
Immunodeficiency DisorderImmunodeficiency Disorder
Immunodeficiency Disorder
 
Secondary immunodeficiency
Secondary immunodeficiencySecondary immunodeficiency
Secondary immunodeficiency
 
Primary combined antibody and cellular immunodeficiencies
Primary combined antibody and cellular immunodeficienciesPrimary combined antibody and cellular immunodeficiencies
Primary combined antibody and cellular immunodeficiencies
 
Combined T cells And Bcell Deficiency - SCID
Combined T cells And Bcell Deficiency - SCIDCombined T cells And Bcell Deficiency - SCID
Combined T cells And Bcell Deficiency - SCID
 
Immunodeficiency Syndrome
Immunodeficiency SyndromeImmunodeficiency Syndrome
Immunodeficiency Syndrome
 
Common variable immunodeficiency
Common variable immunodeficiencyCommon variable immunodeficiency
Common variable immunodeficiency
 
Immunodeficiency disorders: inherited & acquired
Immunodeficiency disorders: inherited & acquiredImmunodeficiency disorders: inherited & acquired
Immunodeficiency disorders: inherited & acquired
 
Immuno deficiency disorders
Immuno deficiency disordersImmuno deficiency disorders
Immuno deficiency disorders
 
Immunodeficiencies.pptx
Immunodeficiencies.pptxImmunodeficiencies.pptx
Immunodeficiencies.pptx
 
immunodeficeincy.pptx
immunodeficeincy.pptximmunodeficeincy.pptx
immunodeficeincy.pptx
 
COMMON VARIABLE IMMUNODEFICIENCY (CVID)
COMMON VARIABLE IMMUNODEFICIENCY (CVID)COMMON VARIABLE IMMUNODEFICIENCY (CVID)
COMMON VARIABLE IMMUNODEFICIENCY (CVID)
 
SECONDARY IMMUNODEFICENCY...pptx
SECONDARY IMMUNODEFICENCY...pptxSECONDARY IMMUNODEFICENCY...pptx
SECONDARY IMMUNODEFICENCY...pptx
 

Recently uploaded

135. Reviewer Certificate in Journal of Engineering
135. Reviewer Certificate in Journal of Engineering135. Reviewer Certificate in Journal of Engineering
135. Reviewer Certificate in Journal of EngineeringManu Mitra
 
129. Reviewer Certificate in BioNature [2024]
129. Reviewer Certificate in BioNature [2024]129. Reviewer Certificate in BioNature [2024]
129. Reviewer Certificate in BioNature [2024]Manu Mitra
 
Transferable Skills - Your Roadmap - Part 1 and 2 - Dirk Spencer Senior Recru...
Transferable Skills - Your Roadmap - Part 1 and 2 - Dirk Spencer Senior Recru...Transferable Skills - Your Roadmap - Part 1 and 2 - Dirk Spencer Senior Recru...
Transferable Skills - Your Roadmap - Part 1 and 2 - Dirk Spencer Senior Recru...Dirk Spencer Corporate Recruiter LION
 
134. Reviewer Certificate in Computer Science
134. Reviewer Certificate in Computer Science134. Reviewer Certificate in Computer Science
134. Reviewer Certificate in Computer ScienceManu Mitra
 
Operating system. short answes and Interview questions .pdf
Operating system. short answes and Interview questions .pdfOperating system. short answes and Interview questions .pdf
Operating system. short answes and Interview questions .pdfharikrishnahari6276
 
Dr. Nazrul Islam, Northern University Bangladesh - CV (29.5.2024).pdf
Dr. Nazrul Islam, Northern University Bangladesh - CV (29.5.2024).pdfDr. Nazrul Islam, Northern University Bangladesh - CV (29.5.2024).pdf
Dr. Nazrul Islam, Northern University Bangladesh - CV (29.5.2024).pdfDr. Nazrul Islam
 
132. Acta Scientific Pharmaceutical Sciences
132. Acta Scientific Pharmaceutical Sciences132. Acta Scientific Pharmaceutical Sciences
132. Acta Scientific Pharmaceutical SciencesManu Mitra
 
0524.THOMASGIRARD_CURRICULUMVITAE-01.pdf
0524.THOMASGIRARD_CURRICULUMVITAE-01.pdf0524.THOMASGIRARD_CURRICULUMVITAE-01.pdf
0524.THOMASGIRARD_CURRICULUMVITAE-01.pdfThomas GIRARD BDes
 
0524.priorspeakingengagementslist-01.pdf
0524.priorspeakingengagementslist-01.pdf0524.priorspeakingengagementslist-01.pdf
0524.priorspeakingengagementslist-01.pdfThomas GIRARD BDes
 
欧洲杯买球平台-欧洲杯买球平台推荐-欧洲杯买球平台| 立即访问【ac123.net】
欧洲杯买球平台-欧洲杯买球平台推荐-欧洲杯买球平台| 立即访问【ac123.net】欧洲杯买球平台-欧洲杯买球平台推荐-欧洲杯买球平台| 立即访问【ac123.net】
欧洲杯买球平台-欧洲杯买球平台推荐-欧洲杯买球平台| 立即访问【ac123.net】foismail170
 
欧洲杯投注网站-欧洲杯投注网站推荐-欧洲杯投注网站| 立即访问【ac123.net】
欧洲杯投注网站-欧洲杯投注网站推荐-欧洲杯投注网站| 立即访问【ac123.net】欧洲杯投注网站-欧洲杯投注网站推荐-欧洲杯投注网站| 立即访问【ac123.net】
欧洲杯投注网站-欧洲杯投注网站推荐-欧洲杯投注网站| 立即访问【ac123.net】foismail170
 
DIGITAL MARKETING COURSE IN CHENNAI.pptx
DIGITAL MARKETING COURSE IN CHENNAI.pptxDIGITAL MARKETING COURSE IN CHENNAI.pptx
DIGITAL MARKETING COURSE IN CHENNAI.pptxFarzanaRbcomcs
 
太阳城娱乐-太阳城娱乐推荐-太阳城娱乐官方网站| 立即访问【ac123.net】
太阳城娱乐-太阳城娱乐推荐-太阳城娱乐官方网站| 立即访问【ac123.net】太阳城娱乐-太阳城娱乐推荐-太阳城娱乐官方网站| 立即访问【ac123.net】
太阳城娱乐-太阳城娱乐推荐-太阳城娱乐官方网站| 立即访问【ac123.net】foismail170
 
Luke Royak's Personal Brand Exploration!
Luke Royak's Personal Brand Exploration!Luke Royak's Personal Brand Exploration!
Luke Royak's Personal Brand Exploration!LukeRoyak
 
Widal Agglutination Test: A rapid serological diagnosis of typhoid fever
Widal Agglutination Test: A rapid serological diagnosis of typhoid feverWidal Agglutination Test: A rapid serological diagnosis of typhoid fever
Widal Agglutination Test: A rapid serological diagnosis of typhoid fevertaexnic
 
D.El.Ed. College List -Session 2024-26.pdf
D.El.Ed. College List -Session 2024-26.pdfD.El.Ed. College List -Session 2024-26.pdf
D.El.Ed. College List -Session 2024-26.pdfbipedoy339
 
Biography and career history of Chad Henson.pdf
Biography and career history of Chad Henson.pdfBiography and career history of Chad Henson.pdf
Biography and career history of Chad Henson.pdfChad Henson
 
Day care leadership document it helps to a person who needs caring children
Day care leadership document it helps to a person who needs caring childrenDay care leadership document it helps to a person who needs caring children
Day care leadership document it helps to a person who needs caring childrenMeleseWolde3
 
欧洲杯投注app-欧洲杯投注app推荐-欧洲杯投注app| 立即访问【ac123.net】
欧洲杯投注app-欧洲杯投注app推荐-欧洲杯投注app| 立即访问【ac123.net】欧洲杯投注app-欧洲杯投注app推荐-欧洲杯投注app| 立即访问【ac123.net】
欧洲杯投注app-欧洲杯投注app推荐-欧洲杯投注app| 立即访问【ac123.net】foismail170
 
0524.THOMASGIRARD_SINGLEPAGERESUME-01.pdf
0524.THOMASGIRARD_SINGLEPAGERESUME-01.pdf0524.THOMASGIRARD_SINGLEPAGERESUME-01.pdf
0524.THOMASGIRARD_SINGLEPAGERESUME-01.pdfThomas GIRARD BDes
 

Recently uploaded (20)

135. Reviewer Certificate in Journal of Engineering
135. Reviewer Certificate in Journal of Engineering135. Reviewer Certificate in Journal of Engineering
135. Reviewer Certificate in Journal of Engineering
 
129. Reviewer Certificate in BioNature [2024]
129. Reviewer Certificate in BioNature [2024]129. Reviewer Certificate in BioNature [2024]
129. Reviewer Certificate in BioNature [2024]
 
Transferable Skills - Your Roadmap - Part 1 and 2 - Dirk Spencer Senior Recru...
Transferable Skills - Your Roadmap - Part 1 and 2 - Dirk Spencer Senior Recru...Transferable Skills - Your Roadmap - Part 1 and 2 - Dirk Spencer Senior Recru...
Transferable Skills - Your Roadmap - Part 1 and 2 - Dirk Spencer Senior Recru...
 
134. Reviewer Certificate in Computer Science
134. Reviewer Certificate in Computer Science134. Reviewer Certificate in Computer Science
134. Reviewer Certificate in Computer Science
 
Operating system. short answes and Interview questions .pdf
Operating system. short answes and Interview questions .pdfOperating system. short answes and Interview questions .pdf
Operating system. short answes and Interview questions .pdf
 
Dr. Nazrul Islam, Northern University Bangladesh - CV (29.5.2024).pdf
Dr. Nazrul Islam, Northern University Bangladesh - CV (29.5.2024).pdfDr. Nazrul Islam, Northern University Bangladesh - CV (29.5.2024).pdf
Dr. Nazrul Islam, Northern University Bangladesh - CV (29.5.2024).pdf
 
132. Acta Scientific Pharmaceutical Sciences
132. Acta Scientific Pharmaceutical Sciences132. Acta Scientific Pharmaceutical Sciences
132. Acta Scientific Pharmaceutical Sciences
 
0524.THOMASGIRARD_CURRICULUMVITAE-01.pdf
0524.THOMASGIRARD_CURRICULUMVITAE-01.pdf0524.THOMASGIRARD_CURRICULUMVITAE-01.pdf
0524.THOMASGIRARD_CURRICULUMVITAE-01.pdf
 
0524.priorspeakingengagementslist-01.pdf
0524.priorspeakingengagementslist-01.pdf0524.priorspeakingengagementslist-01.pdf
0524.priorspeakingengagementslist-01.pdf
 
欧洲杯买球平台-欧洲杯买球平台推荐-欧洲杯买球平台| 立即访问【ac123.net】
欧洲杯买球平台-欧洲杯买球平台推荐-欧洲杯买球平台| 立即访问【ac123.net】欧洲杯买球平台-欧洲杯买球平台推荐-欧洲杯买球平台| 立即访问【ac123.net】
欧洲杯买球平台-欧洲杯买球平台推荐-欧洲杯买球平台| 立即访问【ac123.net】
 
欧洲杯投注网站-欧洲杯投注网站推荐-欧洲杯投注网站| 立即访问【ac123.net】
欧洲杯投注网站-欧洲杯投注网站推荐-欧洲杯投注网站| 立即访问【ac123.net】欧洲杯投注网站-欧洲杯投注网站推荐-欧洲杯投注网站| 立即访问【ac123.net】
欧洲杯投注网站-欧洲杯投注网站推荐-欧洲杯投注网站| 立即访问【ac123.net】
 
DIGITAL MARKETING COURSE IN CHENNAI.pptx
DIGITAL MARKETING COURSE IN CHENNAI.pptxDIGITAL MARKETING COURSE IN CHENNAI.pptx
DIGITAL MARKETING COURSE IN CHENNAI.pptx
 
太阳城娱乐-太阳城娱乐推荐-太阳城娱乐官方网站| 立即访问【ac123.net】
太阳城娱乐-太阳城娱乐推荐-太阳城娱乐官方网站| 立即访问【ac123.net】太阳城娱乐-太阳城娱乐推荐-太阳城娱乐官方网站| 立即访问【ac123.net】
太阳城娱乐-太阳城娱乐推荐-太阳城娱乐官方网站| 立即访问【ac123.net】
 
Luke Royak's Personal Brand Exploration!
Luke Royak's Personal Brand Exploration!Luke Royak's Personal Brand Exploration!
Luke Royak's Personal Brand Exploration!
 
Widal Agglutination Test: A rapid serological diagnosis of typhoid fever
Widal Agglutination Test: A rapid serological diagnosis of typhoid feverWidal Agglutination Test: A rapid serological diagnosis of typhoid fever
Widal Agglutination Test: A rapid serological diagnosis of typhoid fever
 
D.El.Ed. College List -Session 2024-26.pdf
D.El.Ed. College List -Session 2024-26.pdfD.El.Ed. College List -Session 2024-26.pdf
D.El.Ed. College List -Session 2024-26.pdf
 
Biography and career history of Chad Henson.pdf
Biography and career history of Chad Henson.pdfBiography and career history of Chad Henson.pdf
Biography and career history of Chad Henson.pdf
 
Day care leadership document it helps to a person who needs caring children
Day care leadership document it helps to a person who needs caring childrenDay care leadership document it helps to a person who needs caring children
Day care leadership document it helps to a person who needs caring children
 
欧洲杯投注app-欧洲杯投注app推荐-欧洲杯投注app| 立即访问【ac123.net】
欧洲杯投注app-欧洲杯投注app推荐-欧洲杯投注app| 立即访问【ac123.net】欧洲杯投注app-欧洲杯投注app推荐-欧洲杯投注app| 立即访问【ac123.net】
欧洲杯投注app-欧洲杯投注app推荐-欧洲杯投注app| 立即访问【ac123.net】
 
0524.THOMASGIRARD_SINGLEPAGERESUME-01.pdf
0524.THOMASGIRARD_SINGLEPAGERESUME-01.pdf0524.THOMASGIRARD_SINGLEPAGERESUME-01.pdf
0524.THOMASGIRARD_SINGLEPAGERESUME-01.pdf
 

IMMUNODEFICIENCY DISORDERS GROUP 6A.pptx

  • 2.
  • 3. GROUP MEMBERS 1. Alexandria Mungai 2. Keith Nyambeki 3. Lucy Muthoni 4. Elizabeth Makena Netia 5. Johnbosco Muema 6. Yvonne Mwita 7. Chris Karanja
  • 4. DEFINITION Immunodeficiency or immune deficiency is the state in which immune system’s ability to fight infectious disease is compromised or entirely absent.
  • 5. TYPES There are two types of immunodeficiency disorders: 1 Primary immunodeficiency PID: Inherited immune disorders resulting from genetic mutations usually present at birth and diagnosed in childhood. 2 Secondary immunodeficiency (SID): acquired immunodeficiency from a disease or environmental factors such as HIV, malnutrition or medical treatment e.g. chemotherapy.
  • 6. CLASSIFICATION OF PRIMARY IMMUNODEFICIENCY DISEASES 1. Humoral Immunodeficiencies 2. Cellular Immunodeficiencies 3. Combined immunodeficiencies 4. Disorders of complement 5. Disorders of phagocytosis
  • 7. B CELL DEFICIENCY • IgA deficiency • IgG subclass deficiency • Immunodeficiency with increased Igm • Common variable immunodeficiency • Transient hypogammaglobulinemia of infancy • X linked agammaglobulinemia
  • 8. X LINKED AGAMMAGLOBULINEMA • In X-LA early maturation of B cells fails. • Affect mails • Few or no B cells in blood • Very small lymph nodes and tonsils • No Ig. • Small amount of IgG in early age. • Recurrent pyogenic infection.
  • 9. IgA AND IgG SUBCLASS DEFICIENCY • IgA deficiency is most common • Patients tend to develop immune complex disease • About 20% lack IgG2 and IgG4 • Susceptible to pyogenic infection • Results from failure in terminal differentiation of B cells
  • 10. IMMUNODEFICIENCY WITH INCREASED IgM (HIgM) • Results on patients with IgA and IgG deficiency • Production of large amount of IgM >200 mg/dl of polyclonal IgM • Susceptible to pyogenic infection. • Formation of IgM to neutrophils, platelets and other blood components. • Due to inability of B cells to isotype switching.
  • 11. HYPOGLOBULINAEMIA OF INFANCY Due to delay in IgG synthesis approximately up to 36 months. In normal infants synthesis begins at 3 months. Normal B lymphocytes Probably lack help of T lymphocytes
  • 12. DISORDERS OF T CELL DiGeorge’s syndrome: • Also known as Congenic thymic aplasia/hypoplasia. • Associated with hypoparathythoidism, congenital heart disease, fish shaped mouth. • Defects results from abnormal development of fetus during 6th-10th week of gestation when parathyroid, thymus, lips, ears, and aortic arch are being formed.
  • 13. T CELL DEFICIENCIES WITH VARIABLE DEGREES OF B CELL DEFICIENCY 1.Ataxia-telangiectasia: • Associated with a lack of coordination of movement (ataxia) and dilation of small blood vessels of the facial area (telangiectasias). • T-cells and their functions are reduced to various degrees. • B cell numbers and IgM concentrations are normal to low.
  • 14. • IgG is often reduced • IgA is considerably reduced (in 70% of the cases). • There is a high incidence of malignancy particularly leukemia in these patients. • The defects arise from a breakage in chromosome 14 at the site of TCR and Ig heavy chain genes.
  • 15. WISKOTT-ALDRICH SYNDROME • Associated with normal t cell numbers with reduced functions which get progressively worse. • IgM concentrations are reduced but IgG level are normal • Both IgA and IgE levels are elevated. • Boys with this syndrome develop severe eczema. • They respond poorly to polysaccharide antigens and are prone to pyogenic infection.
  • 16. BARE LEUKOCYTE SYNDROME • Due to defect in the MHC class II trans activator (CIITA) protein gene, which results in a lack of class-II MHC molecule on APC. • Patients have fewer CD4 cells and are infection prone. • There are also individuals who have a defect in their transport associated protein (TAP) gene and hence express the class-I MHC molecules and constantly are deficient in CD8+ T cells.
  • 17. DEFECTS OF THE PHAGOCYTIC SYSTEM • Defects of phagocytic cells ( numbers and/or functions) can lead to increased susceptibility to a variety of infections. Cyclic neutropenia: • Its marked by low numbers of circulating neutrophil approximately every three weeks. The neutropenia lasts about a week during which the patients are susceptible to infection. The defect appears to be due to poor regulation of neutrophil production.
  • 18. Chronic granulomatous disease (CGD): CGD is characterized by marked lymphadenopathy, hepato-splenomegaly and chronic draining lymph nodes. In majority of patients with CGD, the deficiency is due to a defect in NADPH oxidase that participate in phagocytic respiratory burst.
  • 19. Leukocyte Adhesion Deficiency • Leukocytes lack the complement receptor CR3 due to a defect in CD11 or CD18 peptides and consequently they cannot respond to C3b opsonin. • Alternatively there may be a defect in integrin molecules, LFA-1 or mac-1 arising from defective CD11a or CD11b peptides, respectively. • These molecules are involved in diapedesis and hence defective neutrophils cannot respond effectively to chemotactic signals.
  • 20. Chediak-Higashi syndrome • This syndrome is marked by reduced (slower rate) intracellular killing and chemotactic movement accompanied by inability of phagosome and lysosome fusion and proteinase deficiency. • Respiratory burst is normal. • Associated with NK cell defect, platelet and neurological disorders.
  • 21. DISORDERS OF COMPLEMENT SYSTEM • Complement abnormalities also lead to increased susceptibility to infections. • There are genetic deficiencies of various components system, which lead to increased infections. • The most serious among these is the C3 deficiency which may arise from low C3 synthesis or deficiency in factor I or factor H.
  • 22. SEVERE COMBINED IMMUNODEFICIENCY • In about 50% of SCID patients the immunodeficiency is x-linked whereas in the other half the deficiency is autosomal. • They both characterized by an absence of T cell and B cell immunity and absence (or very low numbers) of circulating T and B lymphocytes. • Patients with SCID are susceptible to a variety of bacterial, viral, myotic and protozoan infections. • The x-linked SCID is due to a defect in gamma-chain of IL-2 also shared by IL-4, -7, -11 and 15, all involved in lymphocyte proliferation and/or differentiation. • The autosomal SCIDs arise primarily from defects in adenosine deaminase (ADA) or purine nucleoside phosphorylase (PNP) which results is accumulation of dATP or dGTP, respectively, and cause toxicity to lymphoid stem cells.
  • 23. SECONDARY IMMUNODEFICIENCY Secondary immunodeficiency or acquired immunodeficiency, is the loss of immune function and results from exposure to various agents (not a genetic or developmental problem). The most common secondary immunodeficiency is Acquired Immunodeficiency Syndrome (AIDS), which results from infection with the human immunodeficiency virus1 (HIV-1).
  • 24. FOUR STAGES OF INFECTION • Incubation period- the initial incubation period infection is asymptomatic and usually lasts between two and four weeks. • Acute infection- lasts an average of 28 days and can include symptoms such as: 1. Fever 2. Lymphadenopathy(swollen lymph nodes) 3. Pharyngitis(sore throat) 4. Rash 5. Myalgia(muscle pain) 6. Malaise 7. Mouth and esophageal sores • Latency stage- shows few or no symptoms and last anywhere from two to twenty years and beyond.
  • 25. • AIDS- shows as symptoms of various opportunistic infections 0.5% of HIV-1 infected individuals retain high levels of CD4 T-cells and a low or clinically undetectable viral load without anti-retroviral treatment. These individuals are classified as HIV controllers or long-term non progressors (LTNP). The two main types of T-cells are the “helper ”T-cell and the cytotoxic T-cell. The T-helper population is further divided into those which help B-cells (Th2) and those which help cytotoxic T-cells (Th1). Therefore, in order for a B-cell to do its job requires the biochemical help of Th2 helper T-cells; and, for a cytotoxic T- cell to be able to eliminate a damaged cell (say, a virally-infected cell), requires the biochemical help of a Th1 helper T-cell. The effect of HIV on the immune system is the result of a gradual (usually) elimination of the Th1 and Th2 helper T- cell sub-populations.
  • 26.
  • 27. IMMUNODEFICIENCY CAUSED BY DRUGS Corticosteroids • Cause changes in circulating leukocytes. • Depletion of CD4 cells. • Monocytopenia. • Decreased in circulating eosinophils and basophils. • Inhibition of T cell activation and B cell maturation. • Inhibit cytokine synthesis.
  • 28. METHOTREXATE • Structural analogue of folic acid. • Blocks folic acid dependent synthetic pathways essential for DNA synthesis. • Prolonged use for treatment reduces immunoglobulin synthesis. • CYCLOSPORIN • Have severe effects on T cell signaling and functions. • It binds to immunophilins which are believed to have a critical role in signal transduction. • Also inhibit IL2 dependent signal transduction.
  • 29. OTHER CAUSES: • Malnutrition • Minerals • Obesity • Vitamins
  • 30. NURSING MANAGEMENT FOR PATIENTS WITH IMMUNODEFICIENCY DISEASES • Nursing management includes assessment, patient teaching, and supportive care. • Assessment of the patient for infection and for response to treatment is important if it is to be effective. • Nursing care of patients with primary and secondary immunodeficiencies depends on the underlying cause of the immunodeficiency, the type of immunodeficiency, and its severity. • Because immuno-deficiencies result in a compromised immune system and high risk for infection, careful assessment of the patient’s immune status is essential. • The assessment focuses on history of past infec-tions, particularly the type and frequency of infection; signs and symptoms of any current skin, respiratory, gastrointestinal, or genitourinary infection; and measures that prevent infection. • The nurse monitors the patient for signs and symptoms of infection: fever; chills; cough with or without sputum; shortness of breath; difficulty breathing; difficulty swallowing; white patches in the oral cavity; swollen lymph nodes; nausea; vomiting; persistent diarrhea; frequency, urgency, or pain on urination; redness, swelling, or drainage from skin wounds; lesions on the face, lips, or perianal area; persistent vaginal discharge with or without perianal itching; and persistent abdominal pain.
  • 31. NURSING MANAGEMENT CONTINUED • Because the inflammatory response may be blunted, the patient is monitored for subtle and unusual signs and changes in physical status. • Vital signs and the development of pain, neurologic signs, cough, and skin lesions are monitored and reported. • Pulse rate and respiratory rate should be counted for a full minute, as even subtle changes can signal deterioration in the patient’s clin-ical status • Thorough auscultation and assessment of the breath sounds are also key in detecting changes in respiratory status. • Any unusual response to treatment and any significant change in the patient’s clinical condition are promptly reported to the physician. • The nurse also monitors laboratory values (ie, white blood cell count and differential cell count) for changes indicating infection. • Culture and sensitivity reports from wound drainage, lesions, spu-tum, stool, urine, and blood are monitored to identify pathogenic organisms and appropriate antimicrobial therapy. • Changes in laboratory results and subtle changes in clinical status must be reported to the physician because the immunocompromised patient may not develop typical signs and symptoms of infection.
  • 32. NURSING MANAGEMENT CONTINUED • Assessment also focuses on nutritional status; stress level and coping skills; use of alcohol, drugs, or tobacco; and general hy-giene, all of which may affect immune function. • Strategies the patient has used to reduce risk for infection are identified. • Other aspects of nursing care are directed toward reducing the patient’s risk for infection, assisting with medical measures aimed at improving immune status and treating infection, improving the nutritional status, and maintaining bowel and bladder function. • These include careful hand hygiene, encouraging the patient to cough and perform deep-breathing exercises at regular inter-vals, and protecting the integrity of the skin and mucous mem-branes. • All health care personnel must use strict aseptic technique when performing invasive procedures, such as dressing changes, venipunctures, and bladder catheterizations. • Other aspects of nursing care include assisting the patient in managing stress and in adopting a lifestyle that enhances immune system function.

Editor's Notes

  1. In Slide Show mode, select the arrows to visit links.